Equities

Nectar Lifesciences Ltd

NECLIFE:NSI

Nectar Lifesciences Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (INR)42.25
  • Today's Change-1.70 / -3.87%
  • Shares traded3.64m
  • 1 Year change+67.99%
  • Beta1.1154
Data delayed at least 15 minutes, as of Sep 20 2024 11:29 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
OPERATIONS
Net income183(424)341
Depreciation/depletion607591570
Non-Cash items768390685
Cash taxes paid, supplemental000
Cash interest paid, supplemental871795788
Changes in working capital689779(645)
Total cash from operations2,2471,337950
INVESTING
Capital expenditures(294)(301)(250)
Other investing and cash flow items, total124818416
Total cash from investing(170)517166
FINANCING
Financing cash flow items(871)(795)(788)
Total cash dividends paid----(10)
Issuance (retirement) of stock, net------
Issuance (retirement) of debt, net(1183)(1061)(395)
Total cash from financing(2054)(1856)(1194)
NET CHANGE IN CASH
Foreign exchange effects------
Net change in cash22(2.28)(77)
Net cash-begin balance/reserved for future use176178255
Net cash-end balance/reserved for future use198176178
SUPPLEMENTAL INCOME
Depreciation, supplemental607591570
Cash interest paid, supplemental871795788
Cash taxes paid, supplemental000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.